Unpredictable DMD Progression Complicates Sarepta’s Gene Therapy Efficacy Claims

 
• By Derrick Gingery
choice
FDA reviewers must decide whether uncertainty outweighs DMD patients' need for the gene therapy as soon as possible. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies